Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Uber Technologies, Inc. - UBER
From Pomerantz LLP
Via GlobeNewswire
Tickers UBER
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Open Lending Corporation of Class Action Lawsuit and Upcoming Deadlines - LPRO
From Pomerantz LLP
Via GlobeNewswire
Tickers LPRO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of T-Mobile US, Inc. - TMUS
From Pomerantz LLP
Via GlobeNewswire
Tickers TMUS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Greenbrier Companies, Inc. - GBX
From Pomerantz LLP
Via GlobeNewswire
Tickers GBX
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Fluence Energy, Inc. of Class Action Lawsuit and Upcoming Deadlines - FLNC
From Pomerantz LLP
Via GlobeNewswire
Tickers FLNC
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX
From Pomerantz LLP
Via GlobeNewswire
Tickers ALDX
Esperion to Participate in H.C. Wainwright’s 3rd Annual BioConnect Investor Conference
From Esperion Therapeutics, Inc.
Via GlobeNewswire
Tickers ESPR
illumin Reports First Quarter 2025 Financial Results
From illumin
Via GlobeNewswire
Tickers ILLMF TSX:ILLM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRA, FARO, AVDX, GLYC on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Tickers AVDX FARO GLYC PRA
PyroGenesis Schedules First Quarter 2025 Financial Results and Business Update Conference Call
From PyroGenesis Inc.
Via GlobeNewswire
Tickers PYRGF TSX:PYR
Cognition Therapeutics Presented Data at Association for Research in Vision and Ophthalmology Showing Impact on Retinal Cell Health
From Cognition Therapeutics, Inc.
Via GlobeNewswire
Tickers CGTX
Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Trial in the New England Journal of Medicine
From Akero Therapeutics Inc.
Via GlobeNewswire
Tickers AKRO
uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress
From uniQure Inc.
Via GlobeNewswire
Tickers QURE
Onex Reports First Quarter 2025 Results
From ONEX Corporation
Via GlobeNewswire
Tickers TSX:ONEX
Real-World Study Confirms Long-Term Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with the DecisionDx-UM Class Result
From Castle Biosciences, Inc.
Via GlobeNewswire
Tickers CSTL
AMC Networks Inc. Reports First Quarter 2025 Results
From AMC Networks Inc.
Via GlobeNewswire
Tickers AMCX
Gogo Announces First Quarter 2025 Results
From Gogo Business Aviation LLC
Via GlobeNewswire
Tickers GOGO
Vireo Growth Inc. Announces First Quarter 2025 Results
From Vireo Growth Inc.
Via GlobeNewswire
Tickers CSE:VREO VREOF
Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
Bitdeer Announces April 2025 Production and Operations Update
From Bitdeer Technologies Group
Via GlobeNewswire
Tickers BTDR
TeraWulf Reports First Quarter 2025 Results
From TeraWulf Inc.
Via GlobeNewswire
Tickers WULF
Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights
From Boundless Bio, Inc.
Via GlobeNewswire
Tickers BOLD
Taboola to Participate in Upcoming Investor Conferences
From Taboola, Inc.
Via GlobeNewswire
Tickers TBLA
i-80 Gold Announces US$135 Million Bought Deal Public Offering of Units
From i-80 Gold Corp.
Via GlobeNewswire
Tickers IAUX TSX:IAU
Hesai Group to Report First Quarter 2025 Financial Results on Monday, May 26, 2025
From Hesai Group
Via GlobeNewswire
Tickers HSAI
Outbrain Announces First Quarter 2025 Results
From Outbrain Inc.
Via GlobeNewswire
Tickers OB
Gravity Reports First Quarter of 2025 Results and Business Update
From GRAVITY Co., Ltd.
Via GlobeNewswire
Tickers GRVY
Akero Therapeutics Presents Week 96 Results from Phase 2b SYMMETRY Clinical Trial of Efruxifermin in Patients with Compensated Cirrhosis Caused by MASH Showing Fibrosis Improvement without Worsening of MASH at the EASL Congress 2025
From Akero Therapeutics Inc.
Via GlobeNewswire
Tickers AKRO
Bitget Wallet Launches EIP-7702 Detection Tool Upon Ethereum's Pectra Upgrade
From Bitget Limited
Via GlobeNewswire
Agora, Inc. to Report First Quarter 2025 Financial Results on May 27, 2025
From Agora, Inc.
Via GlobeNewswire
Tickers API
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.